Sage Journals: Discover world-class research

Abstract

Keywords

oncology medication safety

Get full access to this article

View all access options for this article.

References

Cecareanu

. A pharmacist perspective on metformin use and cancer outcomes. J Pharm Pract. IN PRESS .

Graham

Punt

Arora

. Clinical pharmacokinetics of metformin. Clin pharmacokinet. 2011;50 (2):81–98.

National Center for Biotechnology Information. PubChem Compound Database; CID=4091. https://pubchem.ncbi.nlm.nih.gov/compound/4091?from=summary#section=Information-Sources. (accessed September 29, 2014).

Proctor

Bourdet

Thakker

. Mechanisms underlying saturable intestinal absorption of metformin. Drug Metabol Dispos. 2008;36 (8):1650–1658.

Tucker

Casey

Phillips

. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol. 1981;12 (2):235–246.

Glucophage Glucophage

[package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2009.

Beckmann

. Absorption, distribution in the organism and elimination of metformin [in German]. Diabetologia. 1969;5 (5):318–324.

Quesada

Tuduri

Ripoll

. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199 (1):5–19.

Robert

Fendri

Hary

. Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. Diabet Metab. 2003;29 (3):279–283.

10.

Wilcock

Bailey

. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica. 1994;24 (1):49–57.

11.

Kimura

Masuda

Tanihara

. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet. 2005;20 (5):379–386.

12.

Duong

Kumar

Kirkpatrick

. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet. 2013;52(5):373–384.